\-\ Texto\\:\\ \ \(0\)\
\-\ palpable\\,\\ firm\\,\\ non\\-mobile\\ right\\ lower\\ abdominal\\ wall\\ mass\\.\\ \\ normal\\ labs\\.\ \(0\)\
\-\ probable\\ excision\\.\ \(0\)\
\-\ lobulated\\ soft\\ tissue\\ mass\\ associated\\ with\\ abdominal\\ wall\\ musculature\\.\\ \\ a\\ portion\\ of\\ it\\ has\\ a\\ complex\\ cystic\\ component\\.\ \(0\)\
\-\ endometrioma\ \(17\)\
\-\ soft\\ tissue\\ tumor\\ \\-\\ mfh\ \(0\)\
\-\ parasitic\\ fibroid\\ \\-\\ secondary\\ to\\ c\\-section\ \(0\)\
\-\ endometrioma\\ \\-\\ secondary\\ to\\ c\\-section\ \(0\)\
\-\ hematoma\ \(500\)\
\-\ abscess\ \(594\)\
\-\ 42\\ yo\\ female\\ presents\\ with\\ abdominal\\ wall\\ mass\\.\\ \\ over\\ the\\ past\\ few\\ years\\ she\\ relates\\ that\\ it\\ may\\ have\\ grown\\ slightly\\ and\\ says\\ it\\ becomes\\ painful\\ and\\ enlarged\\ during\\ menses\\.\\ \\ her\\ last\\ pregancy\\ required\\ a\\ c\\-section\\.\ \(0\)\
\-\ 0\\.8\\%\\ of\\ c\\-section\\ patients\\ have\\ abdominal\\ wall\\ endometrial\\ implants\\ associated\\ with\\ or\\ close\\ to\\ incision\\ site\\.\\ \\ there\\ have\\ a\\ few\\ case\\ reports\\ of\\ parasitic\\ fibroid\\ implants\\ after\\ laparoscopic\\ myomectomies\\ for\\ fibroids\\ as\\ well\\.\\ \\ \ \(0\)\
\-\ hensen\\,\\ et\\ al\\.\\ \\ ajr\\:186\\,\\ march\\ 2006\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ wall\\:\\ 0\\.23366284088819403\ \(0\)\
\-\ implants\\:\\ 0\\.22640937173598752\ \(0\)\
\-\ fibroid\\:\\ 0\\.21077680473721036\ \(0\)\
\-\ abdominal\\:\\ 0\\.21008380361246362\ \(0\)\
\-\ endometrioma\\:\\ 0\\.20890583999744272\ \(0\)\
\-\ parasitic\\:\\ 0\\.20890583999744272\ \(0\)\
\-\ few\\:\\ 0\\.16292059430353198\ \(0\)\
\-\ myomectomies\\:\\ 0\\.1535716961427086\ \(0\)\
\-\ it\\:\\ 0\\.14746811164158546\ \(0\)\
\-\ hensen\\:\\ 0\\.14674595426368997\ \(0\)\
\-\ have\\:\\ 0\\.14391565171240434\ \(0\)\
\-\ relates\\:\\ 0\\.13814653650050926\ \(0\)\
\-\ pregancy\\:\\ 0\\.13814653650050926\ \(0\)\
\-\ mfh\\:\\ 0\\.13507727144965714\ \(0\)\
\-\ grown\\:\\ 0\\.12081356201080452\ \(0\)\
\-\ says\\:\\ 0\\.11965211180745779\ \(0\)\
\-\ secondary\\:\\ 0\\.11383793086132364\ \(0\)\
\-\ menses\\:\\ 0\\.1124563693018862\ \(0\)\
\-\ mass\\:\\ 0\\.1100418440939544\ \(0\)\
\-\ march\\:\\ 0\\.10914487919677168\ \(0\)\
\-\ fibroids\\:\\ 0\\.10855413960799817\ \(0\)\
\-\ incision\\:\\ 0\\.1074314336123852\ \(0\)\
\-\ laparoscopic\\:\\ 0\\.10538840236860518\ \(0\)\
\-\ musculature\\:\\ 0\\.10445291999872136\ \(0\)\
\-\ soft\\:\\ 0\\.10224787158263049\ \(0\)\
\-\ associated\\:\\ 0\\.1012292449337614\ \(0\)\
\-\ tissue\\:\\ 0\\.10074957312573794\ \(0\)\
\-\ probable\\:\\ 0\\.09938401123024423\ \(0\)\
\-\ endometrial\\:\\ 0\\.09808842206355418\ \(0\)\
\-\ 2006\\:\\ 0\\.09576275079835235\ \(0\)\
\-\ becomes\\:\\ 0\\.09189801410621963\ \(0\)\
\-\ lobulated\\:\\ 0\\.08857881772913281\ \(0\)\
\-\ firm\\:\\ 0\\.08705507317120541\ \(0\)\
\-\ close\\:\\ 0\\.08689397767555371\ \(0\)\
\-\ 42\\:\\ 0\\.085362526845654\ \(0\)\
\-\ painful\\:\\ 0\\.08492900029153033\ \(0\)\
\-\ component\\:\\ 0\\.08229326179480187\ \(0\)\
\-\ last\\:\\ 0\\.07810325841251169\ \(0\)\
\-\ site\\:\\ 0\\.07745032085978766\ \(0\)\
\-\ al\\:\\ 0\\.07630107388338307\ \(0\)\
\-\ excision\\:\\ 0\\.0757132812269286\ \(0\)\
\-\ et\\:\\ 0\\.07522529486152088\ \(0\)\
\-\ slightly\\:\\ 0\\.07490765617711977\ \(0\)\
\-\ reports\\:\\ 0\\.07467329948048111\ \(0\)\
\-\ complex\\:\\ 0\\.07398919109534616\ \(0\)\
\-\ to\\:\\ 0\\.07202138087793465\ \(0\)\
\-\ portion\\:\\ 0\\.06866890834212017\ \(0\)\
\-\ required\\:\\ 0\\.06856064847815395\ \(0\)\
\-\ palpable\\:\\ 0\\.06746407061261843\ \(0\)\
\-\ hematoma\\:\\ 0\\.0672131814558336\ \(0\)\
\-\ labs\\:\\ 0\\.06652995461186237\ \(0\)\
\-\ enlarged\\:\\ 0\\.06546442689499342\ \(0\)\
\-\ past\\:\\ 0\\.06250776661736623\ \(0\)\
\-\ abscess\\:\\ 0\\.06166311821388715\ \(0\)\
\-\ during\\:\\ 0\\.060824720027894665\ \(0\)\
\-\ yo\\:\\ 0\\.059993635635141866\ \(0\)\
\-\ her\\:\\ 0\\.059993635635141866\ \(0\)\
\-\ years\\:\\ 0\\.058864652849437704\ \(0\)\
\-\ cystic\\:\\ 0\\.057835157835298134\ \(0\)\
\-\ she\\:\\ 0\\.057163932012628246\ \(0\)\
\-\ with\\:\\ 0\\.056411190339190204\ \(0\)\
\-\ of\\:\\ 0\\.0563775047935101\ \(0\)\
\-\ patients\\:\\ 0\\.054021711914423495\ \(0\)\
\-\ over\\:\\ 0\\.05339649175142723\ \(0\)\
\-\ tumor\\:\\ 0\\.05022887578307413\ \(0\)\
\-\ lower\\:\\ 0\\.049071057978237444\ \(0\)\
\-\ may\\:\\ 0\\.048324952821109025\ \(0\)\
\-\ case\\:\\ 0\\.048244057178513634\ \(0\)\
\-\ after\\:\\ 0\\.04658536937035694\ \(0\)\
\-\ well\\:\\ 0\\.0464978422191284\ \(0\)\
\-\ female\\:\\ 0\\.04633854824852839\ \(0\)\
\-\ presents\\:\\ 0\\.04619503202697591\ \(0\)\
\-\ has\\:\\ 0\\.043863368987400876\ \(0\)\
\-\ that\\:\\ 0\\.04167309861680117\ \(0\)\
\-\ and\\:\\ 0\\.039686542768917955\ \(0\)\
\-\ normal\\:\\ 0\\.03920810391845233\ \(0\)\
\-\ as\\:\\ 0\\.03857836280440425\ \(0\)\
\-\ there\\:\\ 0\\.03820974546850522\ \(0\)\
\-\ or\\:\\ 0\\.033406870440930776\ \(0\)\
\-\ right\\:\\ 0\\.031837673762970586\ \(0\)\
\-\ for\\:\\ 0\\.029105732427048225\ \(0\)\
\-\ the\\:\\ 0\\.019161317429107726\ \(0\)\
